Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

DuPont has no control over the External Site, any data or other content contained therein or any additional linked websites. The link to the External Site is provided for convenience purposes only.

By entering this site you acknowledge and agree that neither DuPont nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the External Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against DuPont and Virtua and further acknowledge and agree that in no event shall DuPont or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to the Legal Notice, this disclaimer or the External Site.

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if DuPont and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

About DuPont

An investment in DuPont is an investment in science, not for science’s sake, but as the engine for DuPont’s business growth.

Our unique combination of sciences, proven research and development, broad global reach and deep market penetration give us distinct competitive advantages. We are the world’s premier science company in the business of finding market-driven solutions that harness the power of science to address some of the world’s biggest challenges: food security, protection of the environment and people, and renewable energy.

For more than five years, DuPont has been executing against a clear strategy to build a higher growth, higher value company. We are focusing our investment in the segments of our portfolio where we can drive innovation to better meet customer needs.

Higher Growth, Higher Value Through Three World-Leading Positions

Our leading sciences give us the opportunity to build a distinctive set of high-market growth businesses in three strategic areas:

            Agriculture and Nutrition – We are extending our leadership in the high-value, science-driven segments of the agriculture-to-food value chains, leveraging linkages across these segments. Market demand in this area is driven by population growth and economic development, creating the need for safer and more abundant foods for our customers.

            Advanced Materials – We continue to strengthen and grow our leading position in differentiated, high-value advanced materials through science-based solutions. This has been an historic strength of DuPont, and we are increasing our lead here.

            Biobased Materials – We are building transformational businesses in areas like biofuels and biomaterials by leveraging our world-class capabilities in critical enabling technologies. We will capitalize on our expertise and resources from our Advanced Materials and Agriculture and Nutrition businesses.

DuPont businesses benefit from our unique and broad portfolio of core technologies that enable new product innovation, sales and margin growth. While our strategy focuses on three key areas of growth, DuPont is organized in seven business segments, allowing us to leverage our science across multiple markets to develop unique science-based solutions. No competitor has our combination of biology, chemistry, materials science and engineering.

Science and Innovation Drive Change to Advance Transformation

Throughout DuPont’s history, our science and innovation have been the sources of our competitive advantage, driving the direction of our portfolio and enabling us to thrive for more than two centuries.

Science and innovation guided us as we took decisive steps to advance our strategy through a series of bold decisions, including our acquisition of Danisco, the sale of Performance Coatings, our acquisition of Pannar Seeds Limited and our plan to separate our Performance Chemicals business through a spinoff to shareholders anticipated to occur in mid-2015. This separation will create two strong and highly competitive companies with distinct strategies, compelling product portfolios, and leading market and customer positions. Both companies will be well positioned to create significant differentiated value for shareholders.

2013 Highlights

  • $2.2 billion invested in Research and Development (6% of sales)
  • About $10 billion in sales from new products (introduced in last 4 years)
  • Three new Innovation Centers: Switzerland, Turkey and the United States
  • ~1,050 U.S. patents granted – the most in DuPont history for a single year
  • ~ 2,500 international patents granted
  • Nearly 1,800 new products commercialized
  • > 150 Research & Development locations worldwide
  • >10,000 scientists and engineers

Strong Execution Drives Results

Focused and deliberate execution of our strategy continues to produce results. DuPont has created strong positions in expanding markets, redeployed capital and resources to growth opportunities, enhanced our offerings, significantly lowered our cost structure and made significant improvements in operating margins.

Our long history of paying dividends continues to be a top priority. In January 2014, the Board authorized a $5 billion share repurchase program, underscoring confidence in our plan to continue increasing the value of DuPont for shareholders. To date in 2014, we have completed $1 billion of this $5 billion program, and we expect to complete $1 billion more in the remainder of the year. In 2012 and 2013, we increased the dividends paid to shareholders of our common stock. In total, in the five year period from 2009 through 2013, DuPont has returned more than $10 billion to shareholders in the form of common dividends paid and share repurchases.

Positioned for Continued Growth and Success

DuPont is well equipped to continue our momentum and increase value for our shareholders as we deliver inventive products and services to our customers worldwide. With operations in 90 countries around the world, we are best positioned to find new demand for existing products, develop localized products to respond to specific problems and create new customer solutions that can be leveraged in our businesses across the globe.

Our global presence, integrated sciences, inclusive innovation and market insight allow us to:

  • Pin-point science-based solutions to real customer problems.
  • Differentiate our products from our competitors.
  • Foster lasting collaborative relationships with industry-leading companies.
  • Create overall sustainable competitive advantage.

Further, it is our commitment to science-led innovation that will build a better future for our customers, strengthen our leadership position in critical new fields and reward our shareholders.

Forward Looking Statements

This contains forward-looking statements and provides forward-looking information. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as “plans,” “expects,” “will,” “anticipates,” "believes," “intends,” and “estimates.” Although they reflect our current expectations, these statements are not guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political conditions; business or supply disruptions; ability to protect and enforce the company’s intellectual property rights successful integration of acquired business and separation of underperforming or non-strategic assets; and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. The company does not undertake to update any forward-looking statements as a result of future developments or new information.

Developing Markets

Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America. A detailed list of all developing countries is available on the Publications page of the Investor Center website at

IR Contacts

Transfer Agent
(888) 983-8766

Shareholder Relations
(302) 774-3034

Institutional Shareholders

Chemours Investor Relations
(302) 773-2263

Chemours Shareholder Relations
(302) 773-1062

Email Alerts

Email Address *
Mailing Lists *

Enter the code shown above.